Dose Insider / GLP-1 sellers / Pepti

PeptiFDA record

FDA records, checked on November 20, 2026

Pepti is named in an FDA warning letter about GLP-1 drugs. We could not read its own site on November 20, 2026. FDA sent it a warning letter on August 24, 2026.

10 FDA letterswarning letter about GLP-1 drugs, latest August 24, 2026
What other sellers showLowest monthly prices on 297 sellers’ sites, November 20, 2026Lowest 10% of sellers$39Median, semaglutide$118Median, tirzepatide$169Highest 10% of sellers$199What other sellers showLowest monthly prices on 297 sellers’ sites,November 20, 2026Lowest 10% of sellers$39Median, semaglutide$118Median, tirzepatide$169Highest 10% of sellers$199

Its own site shows no monthly price we could read; these are what other sellers show.

On this page

What do its site and FDA’s records show?

Websitepepti.co
FDA warning letters on GLP-1 drugs10

What did FDA write to Pepti?

On August 24, 2026 FDA sent TXP Innovations LLC dba Tex Peptides a warning letter under the subject “Unapproved New Drugs/Misbranded”. It quotes the site, for example: Bacteriostatic Water 0.9% Benzyl Alcohol (10 ml).

Read the facts and the full text of the letter.

On August 24, 2026 FDA sent Royal Peptides LLC a warning letter under the subject “Unapproved New Drugs/Misbranded”. It quotes the site, for example: Tirzepatide has become a major focus of metabolic, endocrinology, obesity, and peptide science due to its unique activity at both the GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors.

Read the facts and the full text of the letter.

On August 24, 2026 FDA sent Peptide Partners LLC a warning letter under the subject “Unapproved New Drugs/Misbranded”. It quotes the site, for example: GLP-3 Reta (Retatrutide),.

Read the facts and the full text of the letter.

On August 24, 2026 FDA sent Peak Performance Peptides a warning letter under the subject “Unapproved New Drugs/Misbranded”. It quotes the site, for example: GLP-3R is a synthetic peptide under investigation for its potential effects on metabolic regulation, body weight management, and glycemic control. It acts as a multi-receptor agonist targeting GIP, GLP-1, and glucagon receptors in research settings.

Read the facts and the full text of the letter.

On August 24, 2026 FDA sent NuScience Peptides LLC a warning letter under the subject “Unapproved New Drugs/Misbranded”. It quotes the site, for example: GLP-1 Sema Research Peptide,.

Read the facts and the full text of the letter.

On March 31, 2026 FDA sent Lovega LLC dba Pink Pony Peptides a warning letter under the subject “Unapproved New Drugs Sold Over the Internet”. It quotes the site, for example: laboratory research purposes only.

Read the facts and the full text of the letter.

On March 31, 2026 FDA sent Gram Peptides a warning letter under the subject “Unapproved New Drugs Sold Over the Internet”. It quotes the site, for example: Bacteriostatic Water for Injection.

Read the facts and the full text of the letter.

On February 26, 2025 FDA sent USApeptide.com a warning letter under the subject “Unapproved New Drugs/Misbranded”. It quotes the site, for example: not for human consumption,.

Read the facts and the full text of the letter.

On December 10, 2024 FDA sent Summit Research Peptides a warning letter under the subject “Unapproved New Drugs/Misbranded”. It quotes the site, for example: INTENDED AS A RESEARCH CHEMICAL ONLY,.

Read the facts and the full text of the letter.

On December 10, 2024 FDA sent Prime Vitality, Inc. dba Prime Peptides a warning letter under the subject “Unapproved New Drugs/Misbranded”. It quotes the site, for example: not for human consumption or clinical use,.

Read the facts and the full text of the letter.

Is the price I was quoted high or low?

Enter a monthly price. The chart places it among the lowest monthly prices that 297 sellers show on their own sites.

Price check297 sellers with a price
Drug
Sellers showing less—
Median price shown—

Which sellers show a lower price and have no FDA letter?

245 sellers in our database name the same drugs, show a lower monthly price and have no FDA warning letter about GLP-1 drugs. The six lowest:

The lowest price a site shows is often a first month, a membership fee or the smallest dose; read the sentence on each seller’s page before comparing.

How can I check Pepti myself?

  1. Look the pharmacy up. A compounded GLP-1 is filled by a pharmacy, not by the telehealth company; ask which one, and check its license with the state board of pharmacy. FDA’s BeSafeRx page explains the warning signs of an unsafe online pharmacy.1
  2. Check certification yourself. A LegitScript badge on a site is not proof; LegitScript’s own lookup shows whether a website is certified.2
  3. Read what FDA says about compounded and unapproved GLP-1 drugs before paying for one.3
  4. Search the seller in our database of FDA warning letters.

Sources

  1. FDA. BeSafeRx: your source for online pharmacy information. fda.gov
  2. LegitScript. Website certification status lookup. legitscript.com
  3. FDA. Concerns with unapproved GLP-1 drugs used for weight loss. fda.gov
  4. FDA. Warning letter to TXP Innovations LLC dba Tex Peptides, August 24, 2026. Dose Insider summary with the link to fda.gov
  5. FDA. Warning letter to Royal Peptides LLC, August 24, 2026. Dose Insider summary with the link to fda.gov
  6. FDA. Warning letter to Peptide Partners LLC, August 24, 2026. Dose Insider summary with the link to fda.gov
  7. FDA. Warning letter to Peak Performance Peptides, August 24, 2026. Dose Insider summary with the link to fda.gov
  8. FDA. Warning letter to NuScience Peptides LLC, August 24, 2026. Dose Insider summary with the link to fda.gov
  9. FDA. Warning letter to Lovega LLC dba Pink Pony Peptides, March 31, 2026. Dose Insider summary with the link to fda.gov
  10. FDA. Warning letter to Gram Peptides, March 31, 2026. Dose Insider summary with the link to fda.gov
  11. FDA. Warning letter to USApeptide.com, February 26, 2025. Dose Insider summary with the link to fda.gov
  12. FDA. Warning letter to Summit Research Peptides, December 10, 2024. Dose Insider summary with the link to fda.gov
  13. FDA. Warning letter to Prime Vitality, Inc. dba Prime Peptides, December 10, 2024. Dose Insider summary with the link to fda.gov

Log every dose in mg with the vial it came from, so there is a record if something goes wrong.

Open Dose Insider